S3
. Mass spectrum of farnesyl monophosphate that co-purified with CrtM. The sample was obtained by dissolving CrtM+7+FMP crystals and injecting the solution into an LC-MS instrument.
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Figure S3. Ligand-protein interactions for 41 binding to CrtM. Additionally allowed 1.8 2.5 7.6
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Generously allowed 0.4 0.4 0.5
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Experimental Section
Enzyme expression and purification. S. aureus CrtM was expressed and purified as described previously. 1 Expression and purification of E. coli UPPS and S. aureus UPPS were also carried out as described previously.
2
CrtM inhibition. The S. aureus CrtM inhibition assay was carried out as described in our previous work.
1a
UPPSi. The E. coli UPPS and S. aureus UPPS inhibition assays were carried out as described. Native E. coli UPPS crystals for soaking were obtained by using the hanging-drop method (Hampton Research, Laguna Niguel, CA) by mixing 1 µL of UPPS protein solution (14 mg/ml UPPS in 50 mM HEPES, pH 7.5) with 1 µL of mother liquor (50 mM HEPES, pH 7.5, 5% PEG 2-4K) and then equilibrating with 500 µL mother liquor at room temperature. Crystals grew to 0.3×0.3×0.2 mm in 2 days and were then soaked in a cryoprotectant solution (50 mM HEPES, pH 7.5, 30% EG 5% PEG 35K) containing 2.5-5 mM inhibitor for 1 day.
Diffraction data were collected at sector 21 of the Advanced Photon Source, Argonne National
Laboratory. The data were indexed, integrated and scaled by using the HKL2000 program package. Structures were determined by molecular replacement with the Phaser program, 4 using apo CrtM (PDB ID 2ZCP, minus ligands) as a template. The structure of the UPPS-complex was determined by using a model prepared from the UPPS/BPH-629 complex structure (PDB ID 2E98) with ligands and solvent removed. Further model building, ligand preparation, and refinement employed Coot, 5 ProDRG server, 6 and Refmac in CCP4, 7 respectively. All figures were prepared using PyMol (http://www.pymol.org).
Cell growth inhibition. The growth of S. aureus (USA300 strain) and determination of MIC were as described previously. 
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General procedure for the synthesis of Class I compounds: To a solution of the appropriate amine (0.5 mmol) in dry CH 2 Cl 2 (2 mL) was added dry triethylamine (1 mmol) and (Z)-2-(2,2-dimethyl-5-oxo-1,3-dioxolan-4-ylidene)acetyl chloride at 0 o C. The mixture was stirred for 3 h and then washed with water (4 mL). The organic layer was dried over Na 2 SO 4 , concentrated and subjected to flash chromatography affording the ester, which upon saponification (NaOH, 4 equivalents; 4:1 THF/H 2 O, 10 mL) and acidification gave the final product ~ 60% overall yield. 
(Z)-4-((3-([1,1'-biphenyl]-3-yl)propyl)amino)-2-hydroxy-4-oxobut-2-enoic acid (8).
H NMR (400 MHz
,
(Z)-4-((3-(3-(hexyloxy)phenyl)propyl)amino)-2-hydroxy-4-oxobut-2-enoic acid (9).
H NMR (400 MHz
S8 (Z)-2-hydroxy-4-((3-(naphthalen-2-yl)propyl)amino)-4-oxobut-2-enoic acid (12).
1 H NMR (400 MHz, DMSO-d6) δ 8. 
